EAM Investors’s PAVmed PAVM Stock Holding History

EAM Investors’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,710	Closed	-$6.57M	–	351
2021 Q3	$6.57M	Sell	1,710 -58	-3%	-$183K	1.11%	3
2021 Q2	$5.09M	Buy	+1,768	New	+$4.18M	0.79%	3
2020 Q3	–	Sell	-743	Closed	-$706K	–	336
2020 Q2	$706K	Sell	743 -224	-23%	-$224K	0.16%	232
2020 Q1	$862K	Buy	+967	New	+$791K	0.27%	159

Other funds holding PAVM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

EAM Investors's PAVM Position: Q4 2021 in Review

EAM Investors sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 1,710 shares — an estimated $6.57M sold.

EAM Investors first reported a position in PAVM in Q1 2020 and held it in 4 quarters. The position peaked at $6.57M in Q3 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

EAM Investors reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
EAM Investors sold 1,710 PAVmed shares in Q4 2021, an estimated $6.57M.
EAM Investors first reported a position in PAVmed in Q1 2020 and held it in 4 quarters.
EAM Investors's PAVmed position peaked at $6.57M in Q3 2021.
105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.